Related references
Note: Only part of the references are listed.Ambulatory Toxicity Management (AToM) Pilot: results of a pilot study of a pro-active, telephone-based intervention to improve toxicity management during chemotherapy for breast cancer
Monika K. Krzyzanowska et al.
PILOT AND FEASIBILITY STUDIES (2019)
Severe adverse events impact overall survival and costs in elderly patients with advanced non-small cell lung cancer on second-line therapy
Hossein Borghaei et al.
LUNG CANCER (2018)
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial
Ethan Basch et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Self-evaluation of Adjuvant Chemotherapy-Related Adverse Effects by Patients With Breast Cancer
Filippo Montemurro et al.
JAMA ONCOLOGY (2016)
Inclusion of patient-reported outcome measures in registered clinical trials: Evidence from ClinicalTrials.gov (2007-2013)
E. Vodicka et al.
CONTEMPORARY CLINICAL TRIALS (2015)
Symptomatic Toxicities Experienced During Anticancer Treatment: Agreement Between Patient and Physician Reporting in Three Randomized Trials
Massimo Di Maio et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Patients' self-assessment versus investigators' evaluation in a phase III trial in non-castrate metastatic prostate cancer (GETUG-AFU 15)
Gwenaelle Gravis et al.
EUROPEAN JOURNAL OF CANCER (2014)
What Is the Value of the Routine Use of Patient-Reported Outcome Measures Toward Improvement of Patient Outcomes, Processes of Care, and Health Service Outcomes in Cancer Care? A Systematic Review of Controlled Trials
Grigorios Kotronoulas et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Do High Symptom Scores Trigger Clinical Actions? An Audit After Implementing Electronic Symptom Screening
Hsien Seow et al.
JOURNAL OF ONCOLOGY PRACTICE (2012)
Share Paper
